Référentiel des médicaments
Lunsotogene parvec
Lunsotogene parvec is a medicine in the class miscellaneous.
- Classe médicamenteuse: Miscellaneous
Dernière mise à jour Sources: US FDA label
Réservé aux professionnels de santé — à titre de référence uniquement. Cette page est un bref résumé, pas un avis médical, et ne remplace ni la notice officielle ni le jugement clinique. Vérifiez toujours avant de prescrire ou de délivrer.
Le contenu clinique de cette page n'est disponible qu'en anglais.
L'essentiel
- Classe médicamenteuse
- Miscellaneous
- Formes courantes
- injection
- Noms commerciaux
- 1
- Pays et marchés
- 1
Mécanisme d'action
Intracochlear infusion results in expression of the OTOF gene primarily in inner hair cells, which facilitates production of functional otoferlin protein and restores synaptic transmission to the auditory nerve (shown in mouse studies).
Posologie adulte habituelle (résumé de la notice)
OTOF-associated severe-to-profound sensorineural hearing loss: 7.2 × 10 12 vector genomes (vg) per ear in a total volume of 0.24 mL, single-dose intracochlear infusion; bilateral treatment given in a single surgical session
Grossesse et allaitement
- Grossesse
- Unknown Gene therapy given once by infusion into the inner ear for OTOF-related deafness. No data in pregnancy and no animal reproduction studies. Confirm a negative pregnancy test before treatment in women who could become pregnant.
- Allaitement
- Unknown No data on passage into milk, effects on the breastfed infant or milk production. Most patients are children; for an adult mother, discuss with the treating team before breastfeeding.
Effets indésirables signalés
- Otitis media
- Vomiting
- Nausea
- Dizziness
- Procedural pain
- Gait disturbance
Précautions particulières
- Procedure-related adverse reactions may occur, including vertigo, tinnitus, CSF leak, facial paresis, taste change, meningitis, wound infection, mastoiditis, numbness around the ear, and labyrinthitis; monitor and manage
- Not recommended when preoperative imaging shows inner ear access is not feasible (e.g., abnormal mastoid pneumatization or anatomic variations)
Informez votre pharmacien ou votre médecin en cas de grossesse ou d'allaitement, de maladie rénale ou hépatique, d'allergies, ainsi que de tout autre médicament ou complément que vous prenez.
Réservé aux membres Pro+
Débloquer la page complète
Créez un compte et lancez un essai Pro+ pour ouvrir la monographie complète de Lunsotogene parvec : posologie, grossesse et allaitement, effets indésirables, mises en garde et toutes les interactions.
- Dosing by age, kidney and liver function, and further dose lines
- Renal and hepatic dose adjustments
- Paediatric dosing
- How to give it
- Pharmacokinetics
- Patient counselling points
- IV preparation and dilution
Essayez Pro+ gratuitement pendant 7 jours sur le web. Sans carte.
Autres médicaments de cette classe
Questions fréquentes
What is Lunsotogene parvec used for?
Lunsotogene parvec is a medicine in the class miscellaneous.
What side effects have been reported with Lunsotogene parvec?
Otitis media, Vomiting, Nausea, Dizziness, Procedural pain, Gait disturbance.
Can Lunsotogene parvec be taken in pregnancy or while breastfeeding?
Pregnancy: Unknown. Gene therapy given once by infusion into the inner ear for OTOF-related deafness. No data in pregnancy and no animal reproduction studies. Confirm a negative pregnancy test before treatment in women who could become pregnant. Breastfeeding: Unknown. No data on passage into milk, effects on the breastfed infant or milk production. Most patients are children; for an adult mother, discuss with the treating team before breastfeeding.
What does Lunsotogene parvec interact with?
MediHelp does not list a checked interaction for Lunsotogene parvec yet. Always tell your pharmacist about every medicine you take.
Monographies complètes, posologies et vérificateur d'interactions dans l'application MediHelp
Ouvrez le référentiel complet, vérifiez les interactions entre plusieurs médicaments et utilisez les outils de posologie dans l'application MediHelp.
